0
Pfenex Inc
- 51-200 Employees
- Based in San Diego, California
Pfenex Inc., a clinical-stage biotechnology company, develops biosimilar therapeutics. Its lead product candidate is PF582, a biosimilar candidate to Lucentis that is in Phase Ib/IIa trials in patients with wet age-related macular degeneration.
Pfenex Inc
Most Recent Responsibility Report
MOST RECENT
Request Information
Pfenex Inc does not currently have any reports on ResponsibilityReports.co.uk. Click the button below to be notified when financial info becomes available.
Our service enables potential investors to review the most recent and archived Pfenex Inc Sustainability Report, Pfenex Inc Corporate Social Responsibility Report, Pfenex Inc CSR Report, Pfenex Inc Corporate Responsibility, Pfenex Inc CR Report, Pfenex Inc Citizenship Report, Pfenex Inc ESG Report, and Pfenex Inc Environmental Report online.